Press release article from our research archive:

FDA Approval: First Epilepsy Medication in 25 Years to Be Approved for Use Alone in Children; Trileptal(R) (Oxcarbazepine) Gives Kids With Epilepsy an Important New Treatment Option.

NEW YORK, Aug. 7 /PRNewswire/ -- There's very important news for children with epilepsy -- a disease affecting about a half a million children in the United States. A new use for Trileptal, an antiepileptic drug, has been approved by the U.S. Food and Drug Administration. Trileptal can now be used as monotherapy, or alone, in the treatment of partial seizures in children four years of age and older.

Epilepsy, often referred to as a seizure disorder, is a neurological condition that is associated with recurrent electrical discharges in the brain that disrupt the functioning of the nervous system. The intermittent bursts of electrical energy that result may cause ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!